US Stock MarketDetailed Quotes

TCRT Alaunos Therapeutics

Watchlist
  • 1.8100
  • -0.0500-2.69%
Close Mar 28 16:00 ET
  • 1.8800
  • +0.0700+3.87%
Post 18:57 ET
29.04MMarket Cap-804P/E (TTM)

Alaunos Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
Total revenue
0
4K
0
634.17%2.92M
11K
631.41%2.91M
0
0
398K
0
Operating revenue
--0
--4K
--0
634.17%2.92M
--11K
631.41%2.91M
--0
--0
--398K
--0
Cost of revenue
Gross profit
Operating expense
-35.27%7.23M
-12.12%8.23M
6.46%9.67M
-50.57%38.16M
-17.25%8.53M
-50.76%11.18M
-58.63%9.37M
-57.87%9.09M
-3.92%77.21M
-54.72%10.31M
Selling and administrative expenses
9.02%3.58M
-11.20%3.05M
-9.61%3.17M
-52.32%13.14M
39.62%2.93M
-59.84%3.28M
-62.19%3.43M
-57.40%3.51M
-0.37%27.56M
-76.20%2.1M
-General and administrative expense
9.02%3.58M
----
----
-52.32%13.14M
--2.93M
--3.28M
----
----
--27.56M
----
Research and development costs
-53.68%3.66M
-12.65%5.19M
16.56%6.5M
-49.60%25.02M
-31.76%5.61M
-45.64%7.89M
-56.25%5.94M
-58.16%5.58M
-5.79%49.64M
-41.19%8.22M
Operating profit
12.46%-7.23M
12.16%-8.23M
-6.46%-9.67M
54.12%-35.24M
17.36%-8.52M
62.94%-8.26M
58.63%-9.37M
57.87%-9.09M
4.42%-76.81M
54.72%-10.31M
Net non-operating interest income expense
0
-44.32%-1.07M
-24.89%-853K
-165.26%-3.15M
-19.19%-888K
-89.41%-841K
-740K
-683K
-1.19M
-80.83%-745K
Non-operating interest expense
--0
44.32%1.07M
24.89%853K
165.26%3.15M
19.19%888K
89.41%841K
--740K
--683K
--1.19M
--745K
Other net income (expense)
-588.98%-1.24M
200.00%522K
2,485.00%477K
187.92%662K
133.88%250K
3,528.57%254K
661.29%174K
-322.22%-20K
-295.58%-753K
-278.26%-738K
Special income (charges)
---1.43M
84.21%245K
----
117.97%133K
--0
--0
--133K
----
---740K
---740K
-Less:Restructuring and merger&acquisition
--419K
----
----
----
----
--0
----
----
----
----
-Less:Impairment of capital assets
--1.01M
----
----
--0
--0
--0
----
----
--740K
----
-Less:Other special charges
----
-84.21%-245K
----
---133K
--0
----
---133K
----
----
----
Other non- operating income (expenses)
-25.98%188K
575.61%277K
2,485.00%477K
4,169.23%529K
12,400.00%250K
3,528.57%254K
232.26%41K
-322.22%-20K
-103.38%-13K
-99.52%2K
Income before tax
4.24%-8.48M
11.67%-8.77M
-2.66%-10.05M
52.09%-37.73M
22.34%-9.16M
61.07%-8.85M
56.19%-9.93M
54.59%-9.79M
1.53%-78.75M
48.21%-11.79M
Income tax
Net income
4.24%-8.48M
11.67%-8.77M
-2.66%-10.05M
52.09%-37.73M
22.34%-9.16M
61.07%-8.85M
56.19%-9.93M
54.59%-9.79M
1.53%-78.75M
48.21%-11.79M
Net income continuous Operations
4.24%-8.48M
11.67%-8.77M
-2.66%-10.05M
52.09%-37.73M
22.34%-9.16M
61.07%-8.85M
56.19%-9.93M
54.59%-9.79M
1.53%-78.75M
48.21%-11.79M
Minority interest income
Net income attributable to the parent company
4.24%-8.48M
11.67%-8.77M
-2.66%-10.05M
52.09%-37.73M
22.34%-9.16M
61.07%-8.85M
56.19%-9.93M
54.59%-9.79M
1.53%-78.75M
48.21%-11.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.24%-8.48M
11.67%-8.77M
-2.66%-10.05M
52.09%-37.73M
22.34%-9.16M
61.07%-8.85M
56.19%-9.93M
54.59%-9.79M
1.53%-78.75M
48.21%-11.79M
Basic earnings per share
0.00%-0.6
20.00%-0.6
20.00%-0.6
54.05%-2.55
20.00%-0.6
63.64%-0.6
54.55%-0.75
50.00%-0.75
2.63%-5.55
54.55%-0.75
Diluted earnings per share
0.00%-0.6
20.00%-0.6
20.00%-0.6
54.05%-2.55
20.00%-0.6
63.64%-0.6
54.55%-0.75
50.00%-0.75
2.63%-5.55
54.55%-0.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021
Total revenue 04K0634.17%2.92M11K631.41%2.91M00398K0
Operating revenue --0--4K--0634.17%2.92M--11K631.41%2.91M--0--0--398K--0
Cost of revenue
Gross profit
Operating expense -35.27%7.23M-12.12%8.23M6.46%9.67M-50.57%38.16M-17.25%8.53M-50.76%11.18M-58.63%9.37M-57.87%9.09M-3.92%77.21M-54.72%10.31M
Selling and administrative expenses 9.02%3.58M-11.20%3.05M-9.61%3.17M-52.32%13.14M39.62%2.93M-59.84%3.28M-62.19%3.43M-57.40%3.51M-0.37%27.56M-76.20%2.1M
-General and administrative expense 9.02%3.58M---------52.32%13.14M--2.93M--3.28M----------27.56M----
Research and development costs -53.68%3.66M-12.65%5.19M16.56%6.5M-49.60%25.02M-31.76%5.61M-45.64%7.89M-56.25%5.94M-58.16%5.58M-5.79%49.64M-41.19%8.22M
Operating profit 12.46%-7.23M12.16%-8.23M-6.46%-9.67M54.12%-35.24M17.36%-8.52M62.94%-8.26M58.63%-9.37M57.87%-9.09M4.42%-76.81M54.72%-10.31M
Net non-operating interest income expense 0-44.32%-1.07M-24.89%-853K-165.26%-3.15M-19.19%-888K-89.41%-841K-740K-683K-1.19M-80.83%-745K
Non-operating interest expense --044.32%1.07M24.89%853K165.26%3.15M19.19%888K89.41%841K--740K--683K--1.19M--745K
Other net income (expense) -588.98%-1.24M200.00%522K2,485.00%477K187.92%662K133.88%250K3,528.57%254K661.29%174K-322.22%-20K-295.58%-753K-278.26%-738K
Special income (charges) ---1.43M84.21%245K----117.97%133K--0--0--133K-------740K---740K
-Less:Restructuring and merger&acquisition --419K------------------0----------------
-Less:Impairment of capital assets --1.01M----------0--0--0----------740K----
-Less:Other special charges -----84.21%-245K-------133K--0-------133K------------
Other non- operating income (expenses) -25.98%188K575.61%277K2,485.00%477K4,169.23%529K12,400.00%250K3,528.57%254K232.26%41K-322.22%-20K-103.38%-13K-99.52%2K
Income before tax 4.24%-8.48M11.67%-8.77M-2.66%-10.05M52.09%-37.73M22.34%-9.16M61.07%-8.85M56.19%-9.93M54.59%-9.79M1.53%-78.75M48.21%-11.79M
Income tax
Net income 4.24%-8.48M11.67%-8.77M-2.66%-10.05M52.09%-37.73M22.34%-9.16M61.07%-8.85M56.19%-9.93M54.59%-9.79M1.53%-78.75M48.21%-11.79M
Net income continuous Operations 4.24%-8.48M11.67%-8.77M-2.66%-10.05M52.09%-37.73M22.34%-9.16M61.07%-8.85M56.19%-9.93M54.59%-9.79M1.53%-78.75M48.21%-11.79M
Minority interest income
Net income attributable to the parent company 4.24%-8.48M11.67%-8.77M-2.66%-10.05M52.09%-37.73M22.34%-9.16M61.07%-8.85M56.19%-9.93M54.59%-9.79M1.53%-78.75M48.21%-11.79M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.24%-8.48M11.67%-8.77M-2.66%-10.05M52.09%-37.73M22.34%-9.16M61.07%-8.85M56.19%-9.93M54.59%-9.79M1.53%-78.75M48.21%-11.79M
Basic earnings per share 0.00%-0.620.00%-0.620.00%-0.654.05%-2.5520.00%-0.663.64%-0.654.55%-0.7550.00%-0.752.63%-5.5554.55%-0.75
Diluted earnings per share 0.00%-0.620.00%-0.620.00%-0.654.05%-2.5520.00%-0.663.64%-0.654.55%-0.7550.00%-0.752.63%-5.5554.55%-0.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg